Clinical trial
Lay User Evaluation of the Panbio™ HCV Self Test in an EU Population
NCT06492018 is registered in ClinicalTrials.gov with Abbott Rapid Dx as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lay User Evaluation of the Panbio™ HCV Self Test in an EU Population
- Lead sponsor
- Abbott Rapid Dx
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- December 1, 2024
- Completion date
- March 30, 2025
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.